Target intelligence / Profile preview

Deoxygenation-induced cation conductance (Psickle)

Target
Psickle
Molecular classification
Ion channel, Non-selective cation channel
01

Overview

The sickle-induced non-selective cation leak pathway, commonly known as Psickle, is a deoxygenation-induced membrane conductance characteristic of red blood cells (RBCs) in sickle cell disease (SCD) [1, 3]. Upon deoxygenation and the subsequent polymerization of hemoglobin S (HbS), the RBC membrane becomes permeable to cations, allowing the influx of calcium (Ca2+) and sodium (Na+) and the efflux of potassium (K+) [1, 6]. This ion flux leads to cellular dehydration, which increases the intracellular concentration of HbS and further promotes polymerization and sickling, creating a pathophysiological cycle of cell damage [3, 8]. While its exact molecular identity has been a subject of research, recent evidence identifies the mechanosensitive ion channel PIEZO1 as a primary component, with additional contributions from N-methyl-D-aspartate (NMDA) receptors and potentially other channels like TRPC6 or Aquaporin-1 [3, 4, 10]. Pharmacological targeting of this pathway, such as through NMDA receptor antagonists like memantine or PIEZO1 inhibitors, aims to prevent the calcium-induced activation of the Gárdos channel and the resulting dehydration, offering a therapeutic strategy to improve RBC survival and reduce vaso-occlusive complications in SCD patients [4, 5, 6].

Other names
Sickle-induced non-selective cation leak pathwayPsickle pathwayDeoxygenation-induced cation leakSickle cell cation leakSickle-induced cation conductance
02

Mechanism of action

Inhibition of the non-selective cation conductance to prevent calcium influx and subsequent activation of the Gárdos channel, thereby reducing red blood cell dehydration and sickling.

03

Biological functions

Ion transportCalcium homeostasisCell volume regulation
04

Disease associations

Sickle cell diseaseHemolytic anemia
05

Safety considerations

Off-target effects on mechanosensitive channels in other tissues (e.g., vascular or lymphatic systems)Potential neurological side effects from NMDA receptor inhibitionMaintenance of normal red blood cell volume regulation and mechanical stability
06

Interacting drugs

Memantine

3 more in the full profile.

07

Biomarkers

Intracellular calcium concentrationRed blood cell densityPercentage of sickled cellsHemolysis markers (e.g., lactate dehydrogenase, bilirubin)

Beyond the preview

Go deeper on Deoxygenation-induced cation conductance (Psickle).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Deoxygenation-induced cation conductance (Psickle).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call